Pharmaceutical Formulation is a comprehensive process that transforms active pharmaceutical ingredients (APIs) into a final medicinal product. It encompasses a series of intricate steps to design and develop formulations that ensure the optimal delivery, stability, and efficacy of medications.
The formulation process begins with a thorough understanding of the chemical and physical properties of the active ingredients. Considerations such as dosage form, route of administration, and patient compliance play crucial roles in pharmaceutical formulation. This process is not only focused on ensuring the effectiveness of the drug but also on providing patients with convenient and acceptable forms of medication. The goal is to develop formulations that maintain stability, control release profiles, and minimize adverse effects.
Integral components of Pharmaceutical Formulation includes:
Quality control and Assurance are, ensuring that each batch meets stringent standards for safety, efficacy, and consistency. Continuous research and development in this field contribute to the evolution of innovative formulations that address specific therapeutic needs and improve the overall patient experience.
At its core, Pharmaceutical formulation is dedicated to the creation of drug products that are not only scientifically robust but also attuned to the needs and experiences of patients.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia